ArticleJournal of pharmaceutical policy and practice2021

A comparison of the Food and Drug Administration's and Health Canada's regulatory decisions about failed confirmatory trials for oncology drugs: an observational study.

Joel LexchinPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.